Luoxin Pharmaceuticals Group Stock Co., Ltd.
SZSE:002793.SZ
5.28 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||
| Current Assets: | |||||||||||||
| Cash & Cash Equivalents
| 692.899 | 1,433.805 | 2,001.722 | 1,287.575 | 1,108.523 | 323.353 | 125.76 | 140.127 | 79.971 | 48.878 | 52.645 | 64.179 | 65.303 |
| Short Term Investments
| 2.1 | 17.1 | 12.579 | -98.987 | 106.841 | 83.043 | 1.296 | 0.006 | 1,049.556 | 0.279 | 1,155 | 2.191 | 0 |
| Cash and Short Term Investments
| 694.999 | 1,450.905 | 2,014.301 | 1,287.575 | 1,215.364 | 323.353 | 127.056 | 140.133 | 79.971 | 49.157 | 52.645 | 66.37 | 65.303 |
| Net Receivables
| 850.9 | 2,316.603 | 3,477.792 | 2,833.33 | 2,414.811 | 194.523 | 168.833 | 133.546 | 126.476 | 99.384 | 77.321 | 59.044 | 50.475 |
| Inventory
| 455.611 | 684.986 | 709.077 | 645.814 | 740.917 | 193.222 | 179.726 | 150.58 | 106.889 | 97.794 | 81.436 | 97.425 | 94.391 |
| Other Current Assets
| 66 | 269.399 | 167.218 | 113.683 | 502.876 | 106.131 | 1.564 | 102.142 | 2.43 | 0.678 | 0.201 | 8.776 | -5.743 |
| Total Current Assets
| 2,067.511 | 4,721.893 | 6,368.388 | 4,880.401 | 4,873.967 | 817.228 | 477.179 | 526.401 | 315.765 | 247.014 | 211.602 | 231.615 | 204.426 |
| Non-Current Assets: | |||||||||||||
| Property, Plant & Equipment, Net
| 1,629.549 | 1,777.273 | 2,071.069 | 1,921.466 | 1,754.938 | 390.201 | 226.151 | 207.859 | 158.108 | 124.267 | 75.994 | 65.302 | 60.358 |
| Goodwill
| 1.953 | 4.378 | 9.757 | 8.81 | 6.385 | 6.385 | 0 | 0.165 | 0.165 | 0.165 | 0.165 | 0.165 | 0 |
| Intangible Assets
| 701.151 | 646.47 | 650.295 | 601.879 | 513.859 | 186.941 | 191.391 | 74.462 | 71.634 | 73.164 | 74.512 | 74.755 | 6.126 |
| Goodwill and Intangible Assets
| 703.104 | 650.848 | 660.051 | 610.69 | 520.244 | 186.941 | 191.391 | 74.462 | 71.634 | 73.164 | 74.512 | 74.755 | 6.126 |
| Long Term Investments
| 369.549 | 214.861 | 52.664 | 165.642 | -44.055 | -28.824 | 0 | 89.335 | 70.287 | 41 | 41 | 1 | 0 |
| Tax Assets
| 286.15 | 417.543 | 183.669 | 126.055 | 136.364 | 7.353 | 4.104 | 3.977 | 4.093 | 3.416 | 1.193 | 0.636 | 1.032 |
| Other Non-Current Assets
| 61.543 | 325.408 | 160.989 | 17.445 | 219.102 | 28.833 | 0.101 | -89.141 | -70.287 | -41 | -41 | -1 | 0 |
| Total Non-Current Assets
| 3,049.896 | 3,385.932 | 3,128.442 | 2,841.298 | 2,586.593 | 584.504 | 421.748 | 286.492 | 233.835 | 200.846 | 151.699 | 140.693 | 67.515 |
| Total Assets
| 5,117.407 | 8,107.824 | 9,496.83 | 7,721.7 | 7,460.56 | 1,401.732 | 898.927 | 812.893 | 549.6 | 447.86 | 363.302 | 372.308 | 271.941 |
| Liabilities & Equity: | |||||||||||||
| Current Liabilities: | |||||||||||||
| Account Payables
| 384.894 | 512.252 | 899.768 | 851.522 | 1,094.241 | 84.064 | 83.919 | 74.488 | 77.124 | 68.415 | 70.41 | 76.181 | 71.281 |
| Short Term Debt
| 1,024.98 | 3,264.849 | 2,222.445 | 1,122.944 | 780.88 | 110 | -30.191 | -17.432 | 100.42 | 13.142 | 22.194 | 74.714 | 21.472 |
| Tax Payables
| 1.79 | 22.595 | 228.54 | 237.696 | 226.475 | 9.658 | 12.691 | 9.632 | 6.431 | 5.577 | 3.576 | 0.09 | 11.87 |
| Deferred Revenue
| 134.282 | 169.283 | 864.427 | 973.392 | 966.865 | 9.658 | 30.191 | 17.432 | 24.301 | 24.355 | 12.445 | 7.959 | 17.809 |
| Other Current Liabilities
| 373.401 | 428.435 | 20.637 | 18.857 | 108.93 | 43.497 | 55.9 | 37.379 | 8.26 | 8.447 | 6.753 | 7.591 | 9.51 |
| Total Current Liabilities
| 1,917.556 | 4,374.818 | 4,007.277 | 2,966.714 | 2,950.916 | 247.218 | 139.819 | 111.866 | 210.104 | 114.359 | 111.802 | 166.444 | 120.072 |
| Non-Current Liabilities: | |||||||||||||
| Long Term Debt
| 429.232 | 253.81 | 624.26 | 303.327 | 463.981 | 218.451 | 0 | 0 | 0 | 18 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 89.934 | 93.581 | 102.224 | 101.299 | 83.908 | 26.177 | 4.728 | 2.692 | 0 | -18 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 7.585 | 0 | -0 | 303.327 | -463.981 | -218.451 | 0.194 | 0.001 | 0 | 0.042 | 0 | 0.329 | 0 |
| Other Non-Current Liabilities
| 10.756 | 79.137 | 27.279 | -303.327 | 463.981 | 218.451 | 0 | 0 | 0 | 18 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 537.508 | 426.528 | 753.763 | 404.626 | 547.889 | 244.628 | 4.922 | 2.693 | 0 | 18.042 | 0 | 0.329 | 0 |
| Total Liabilities
| 2,455.064 | 4,801.346 | 4,761.04 | 3,371.341 | 3,498.806 | 491.846 | 144.742 | 114.559 | 210.104 | 132.401 | 111.802 | 166.773 | 120.072 |
| Equity: | |||||||||||||
| Preferred Stock
| 0 | 0 | 40.771 | 66.331 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 1,087.588 | 1,087.588 | 1,463.689 | 1,467.223 | 1,435.176 | 200 | 200 | 100 | 75 | 75 | 75 | 75 | 54.945 |
| Retained Earnings
| 875.215 | 1,535.576 | 2,788.9 | 2,440.241 | 2,191.445 | 378.026 | 297.794 | 253.511 | 163.148 | 147.249 | 89.667 | 48.3 | 63.193 |
| Accumulated Other Comprehensive Income/Loss
| 40.677 | 42.733 | -40.771 | -66.331 | 52.457 | 59.916 | 46.048 | 34.478 | 101.348 | 0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 466.421 | 508.209 | 131.997 | 133.043 | 0 | 271.944 | 210.344 | 310.344 | 0 | 93.21 | 86.832 | 82.236 | 33.731 |
| Total Shareholders Equity
| 2,469.901 | 3,174.106 | 4,384.587 | 4,040.506 | 3,679.079 | 909.886 | 754.185 | 698.334 | 339.496 | 315.459 | 251.5 | 205.536 | 151.869 |
| Total Equity
| 2,572.409 | 3,306.478 | 4,735.789 | 4,350.359 | 3,961.755 | 1,119.952 | 754.185 | 746.552 | 358.756 | 319.255 | 254.984 | 207.433 | 151.869 |
| Total Liabilities & Shareholders Equity
| 5,117.407 | 8,107.824 | 9,496.83 | 7,721.7 | 7,460.56 | 1,401.732 | 898.927 | 812.893 | 549.6 | 447.86 | 363.302 | 372.308 | 271.941 |